YAP-mediated GPER signaling impedes proliferation and survival of prostate epithelium in benign prostatic hyperplasia
2024 · iScience · 10 citations
https://doi.org/10.1016/j.isci.2024.109125
J
Jindong Sheng
Tianjin Medical University Cancer Institute and Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
521
Citations
13
h-index
14
i10-index
Jindong Sheng is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Urinary Bladder and Prostate Research & Cancer Immunotherapy and Biomarkers & Prostate Cancer Treatment and Research. The author has an h-index of 13, co-authored 23 publications.
Papers by this author
worksTislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study
2025 · Signal Transduction and Targeted Therapy · 7 citations
https://doi.org/10.1038/s41392-025-02294-9
<scp>RPL35A</scp> drives ovarian cancer progression by promoting the binding of <scp>YY1</scp> to <scp>CTCF</scp> promoter
2024 · Journal of Cellular and Molecular Medicine · 4 citations
https://doi.org/10.1111/jcmm.18115
Clonal origins and divergent evolutionary relationships of synchronous multiple malignant neoplasms in gynecology revealed by next-generation sequencing
2025 · Cancer Treatment and Research Communications · 0 citations
https://doi.org/10.1016/j.ctarc.2025.101013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat